HEADER BIOSYNTHETIC PROTEIN 02-OCT-14 4RHP TITLE CRYSTAL STRUCTURE OF HUMAN COQ9 IN COMPLEX WITH A PHOSPHOLIPID, TITLE 2 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR5043 COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUINONE BIOSYNTHESIS PROTEIN COQ9, MITOCHONDRIAL; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 84-318 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS STRUCTURAL GENOMICS, PSI-BIOLOGY, NORTHEAST STRUCTURAL GENOMICS KEYWDS 2 CONSORTIUM, NESG, ALL ALPHA-HELICAL PROTEIN, UBIQUINONE KEYWDS 3 BIOSYNTHESIS, MITOCHONDRIAL, MITOCHONDRIAL PROTEIN PARTNERSHIP, MPP, KEYWDS 4 BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR F.FOROUHAR,S.LEW,J.SEETHARAMAN,H.WANG,D.LEE,S.KOGAN,M.MAGLAQUI, AUTHOR 2 R.XIAO,J.K.EVERETT,G.T.MONTELIONE,J.F.HUNT,L.TONG,NORTHEAST AUTHOR 3 STRUCTURAL GENOMICS CONSORTIUM (NESG),MITOCHONDRIAL PROTEIN AUTHOR 4 PARTNERSHIP (MPP) REVDAT 7 16-OCT-24 4RHP 1 REMARK REVDAT 6 14-AUG-19 4RHP 1 REMARK REVDAT 5 17-JUL-19 4RHP 1 REMARK LINK REVDAT 4 22-NOV-17 4RHP 1 REMARK REVDAT 3 19-NOV-14 4RHP 1 JRNL REVDAT 2 29-OCT-14 4RHP 1 JRNL REVDAT 1 22-OCT-14 4RHP 0 JRNL AUTH D.C.LOHMAN,F.FOROUHAR,E.T.BEEBE,M.S.STEFELY,C.E.MINOGUE, JRNL AUTH 2 A.ULBRICH,J.A.STEFELY,S.SUKUMAR,M.LUNA-SANCHEZ,A.JOCHEM, JRNL AUTH 3 S.LEW,J.SEETHARAMAN,R.XIAO,H.WANG,M.S.WESTPHALL,R.L.WROBEL, JRNL AUTH 4 J.K.EVERETT,J.C.MITCHELL,L.C.LOPEZ,J.J.COON,L.TONG, JRNL AUTH 5 D.J.PAGLIARINI JRNL TITL MITOCHONDRIAL COQ9 IS A LIPID-BINDING PROTEIN THAT JRNL TITL 2 ASSOCIATES WITH COQ7 TO ENABLE COENZYME Q BIOSYNTHESIS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 111 E4697 2014 JRNL REFN ISSN 0027-8424 JRNL PMID 25339443 JRNL DOI 10.1073/PNAS.1413128111 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.79 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 18450 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.220 REMARK 3 FREE R VALUE TEST SET COUNT : 1885 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.8241 - 5.6241 1.00 1305 154 0.1872 0.2220 REMARK 3 2 5.6241 - 4.4650 1.00 1289 148 0.1738 0.2316 REMARK 3 3 4.4650 - 3.9009 1.00 1289 128 0.1498 0.1987 REMARK 3 4 3.9009 - 3.5443 1.00 1280 154 0.1658 0.2108 REMARK 3 5 3.5443 - 3.2904 1.00 1309 140 0.1785 0.2708 REMARK 3 6 3.2904 - 3.0964 1.00 1274 147 0.1756 0.2382 REMARK 3 7 3.0964 - 2.9414 1.00 1258 157 0.1888 0.2866 REMARK 3 8 2.9414 - 2.8133 1.00 1274 154 0.1969 0.3393 REMARK 3 9 2.8133 - 2.7050 1.00 1273 138 0.1935 0.2660 REMARK 3 10 2.7050 - 2.6117 1.00 1284 158 0.1959 0.2903 REMARK 3 11 2.6117 - 2.5300 1.00 1265 141 0.1847 0.2861 REMARK 3 12 2.5300 - 2.4577 1.00 1284 146 0.2075 0.2742 REMARK 3 13 2.4577 - 2.3930 0.93 1181 120 0.2237 0.3358 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 44.65 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.83690 REMARK 3 B22 (A**2) : -1.43750 REMARK 3 B33 (A**2) : -0.39940 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.28610 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3255 REMARK 3 ANGLE : 1.117 4404 REMARK 3 CHIRALITY : 0.074 490 REMARK 3 PLANARITY : 0.004 567 REMARK 3 DIHEDRAL : 15.325 1203 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -13.6155 -24.8997 -33.7711 REMARK 3 T TENSOR REMARK 3 T11: 0.0967 T22: 0.1214 REMARK 3 T33: 0.1357 T12: -0.0129 REMARK 3 T13: -0.0085 T23: 0.0034 REMARK 3 L TENSOR REMARK 3 L11: 0.3435 L22: 0.5055 REMARK 3 L33: 0.7825 L12: -0.0483 REMARK 3 L13: -0.0397 L23: -0.1259 REMARK 3 S TENSOR REMARK 3 S11: 0.0059 S12: -0.0480 S13: 0.0350 REMARK 3 S21: 0.0249 S22: -0.0578 S23: 0.0049 REMARK 3 S31: -0.0843 S32: -0.0050 S33: -0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RHP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-OCT-14. REMARK 100 THE DEPOSITION ID IS D_1000087359. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97937 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35868 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 48.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : 0.06100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.6800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.51400 REMARK 200 R SYM FOR SHELL (I) : 0.46400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SNB, RESOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS (PH 8.5), 20% (V/V) PEG REMARK 280 3350, AND 200 MM MGCL2 , MIRCOBATCH UNDER OIL, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.81400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 84 REMARK 465 GLN A 85 REMARK 465 GLY A 86 REMARK 465 GLY A 87 REMARK 465 GLU A 88 REMARK 465 GLU A 89 REMARK 465 GLU A 90 REMARK 465 GLU A 91 REMARK 465 ASP A 92 REMARK 465 TYR A 93 REMARK 465 GLU A 94 REMARK 465 GLY A 284 REMARK 465 HIS A 285 REMARK 465 THR A 286 REMARK 465 ALA A 287 REMARK 465 LYS A 288 REMARK 465 GLN A 289 REMARK 465 VAL A 290 REMARK 465 LYS A 291 REMARK 465 SER A 292 REMARK 465 THR A 293 REMARK 465 GLY A 294 REMARK 465 GLU A 295 REMARK 465 ALA A 296 REMARK 465 LEU A 297 REMARK 465 VAL A 298 REMARK 465 GLN A 299 REMARK 465 GLY A 300 REMARK 465 LEU A 301 REMARK 465 MSE A 302 REMARK 465 GLY A 303 REMARK 465 ALA A 304 REMARK 465 ALA A 305 REMARK 465 VAL A 306 REMARK 465 THR A 307 REMARK 465 LEU A 308 REMARK 465 LYS A 309 REMARK 465 ASN A 310 REMARK 465 LEU A 311 REMARK 465 THR A 312 REMARK 465 GLY A 313 REMARK 465 LEU A 314 REMARK 465 ASN A 315 REMARK 465 GLN A 316 REMARK 465 ARG A 317 REMARK 465 ARG A 318 REMARK 465 ASP B 84 REMARK 465 GLN B 85 REMARK 465 GLY B 86 REMARK 465 GLY B 87 REMARK 465 GLU B 88 REMARK 465 GLU B 89 REMARK 465 GLU B 90 REMARK 465 GLU B 91 REMARK 465 ASP B 92 REMARK 465 GLN B 234 REMARK 465 SER B 235 REMARK 465 THR B 236 REMARK 465 ASP B 237 REMARK 465 HIS B 285 REMARK 465 THR B 286 REMARK 465 ALA B 287 REMARK 465 LYS B 288 REMARK 465 GLN B 289 REMARK 465 VAL B 290 REMARK 465 LYS B 291 REMARK 465 SER B 292 REMARK 465 THR B 312 REMARK 465 GLY B 313 REMARK 465 LEU B 314 REMARK 465 ASN B 315 REMARK 465 GLN B 316 REMARK 465 ARG B 317 REMARK 465 ARG B 318 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 235 74.95 -101.38 REMARK 500 THR A 236 142.71 178.11 REMARK 500 MSE B 137 13.77 -166.39 REMARK 500 LYS B 140 -8.78 -50.66 REMARK 500 ALA B 231 -72.21 -62.21 REMARK 500 MSE B 283 51.56 82.53 REMARK 500 ASN B 310 36.46 -81.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PEF A 401 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEF A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: NESG-HR5043 RELATED DB: TARGETTRACK DBREF 4RHP A 84 318 UNP O75208 COQ9_HUMAN 84 318 DBREF 4RHP B 84 318 UNP O75208 COQ9_HUMAN 84 318 SEQRES 1 A 235 ASP GLN GLY GLY GLU GLU GLU GLU ASP TYR GLU SER GLU SEQRES 2 A 235 GLU GLN LEU GLN HIS ARG ILE LEU THR ALA ALA LEU GLU SEQRES 3 A 235 PHE VAL PRO ALA HIS GLY TRP THR ALA GLU ALA ILE ALA SEQRES 4 A 235 GLU GLY ALA GLN SER LEU GLY LEU SER SER ALA ALA ALA SEQRES 5 A 235 SER MSE PHE GLY LYS ASP GLY SER GLU LEU ILE LEU HIS SEQRES 6 A 235 PHE VAL THR GLN CYS ASN THR ARG LEU THR ARG VAL LEU SEQRES 7 A 235 GLU GLU GLU GLN LYS LEU VAL GLN LEU GLY GLN ALA GLU SEQRES 8 A 235 LYS ARG LYS THR ASP GLN PHE LEU ARG ASP ALA VAL GLU SEQRES 9 A 235 THR ARG LEU ARG MSE LEU ILE PRO TYR ILE GLU HIS TRP SEQRES 10 A 235 PRO ARG ALA LEU SER ILE LEU MSE LEU PRO HIS ASN ILE SEQRES 11 A 235 PRO SER SER LEU SER LEU LEU THR SER MSE VAL ASP ASP SEQRES 12 A 235 MSE TRP HIS TYR ALA GLY ASP GLN SER THR ASP PHE ASN SEQRES 13 A 235 TRP TYR THR ARG ARG ALA MSE LEU ALA ALA ILE TYR ASN SEQRES 14 A 235 THR THR GLU LEU VAL MSE MSE GLN ASP SER SER PRO ASP SEQRES 15 A 235 PHE GLU ASP THR TRP ARG PHE LEU GLU ASN ARG VAL ASN SEQRES 16 A 235 ASP ALA MSE ASN MSE GLY HIS THR ALA LYS GLN VAL LYS SEQRES 17 A 235 SER THR GLY GLU ALA LEU VAL GLN GLY LEU MSE GLY ALA SEQRES 18 A 235 ALA VAL THR LEU LYS ASN LEU THR GLY LEU ASN GLN ARG SEQRES 19 A 235 ARG SEQRES 1 B 235 ASP GLN GLY GLY GLU GLU GLU GLU ASP TYR GLU SER GLU SEQRES 2 B 235 GLU GLN LEU GLN HIS ARG ILE LEU THR ALA ALA LEU GLU SEQRES 3 B 235 PHE VAL PRO ALA HIS GLY TRP THR ALA GLU ALA ILE ALA SEQRES 4 B 235 GLU GLY ALA GLN SER LEU GLY LEU SER SER ALA ALA ALA SEQRES 5 B 235 SER MSE PHE GLY LYS ASP GLY SER GLU LEU ILE LEU HIS SEQRES 6 B 235 PHE VAL THR GLN CYS ASN THR ARG LEU THR ARG VAL LEU SEQRES 7 B 235 GLU GLU GLU GLN LYS LEU VAL GLN LEU GLY GLN ALA GLU SEQRES 8 B 235 LYS ARG LYS THR ASP GLN PHE LEU ARG ASP ALA VAL GLU SEQRES 9 B 235 THR ARG LEU ARG MSE LEU ILE PRO TYR ILE GLU HIS TRP SEQRES 10 B 235 PRO ARG ALA LEU SER ILE LEU MSE LEU PRO HIS ASN ILE SEQRES 11 B 235 PRO SER SER LEU SER LEU LEU THR SER MSE VAL ASP ASP SEQRES 12 B 235 MSE TRP HIS TYR ALA GLY ASP GLN SER THR ASP PHE ASN SEQRES 13 B 235 TRP TYR THR ARG ARG ALA MSE LEU ALA ALA ILE TYR ASN SEQRES 14 B 235 THR THR GLU LEU VAL MSE MSE GLN ASP SER SER PRO ASP SEQRES 15 B 235 PHE GLU ASP THR TRP ARG PHE LEU GLU ASN ARG VAL ASN SEQRES 16 B 235 ASP ALA MSE ASN MSE GLY HIS THR ALA LYS GLN VAL LYS SEQRES 17 B 235 SER THR GLY GLU ALA LEU VAL GLN GLY LEU MSE GLY ALA SEQRES 18 B 235 ALA VAL THR LEU LYS ASN LEU THR GLY LEU ASN GLN ARG SEQRES 19 B 235 ARG MODRES 4RHP MSE A 137 MET SELENOMETHIONINE MODRES 4RHP MSE A 192 MET SELENOMETHIONINE MODRES 4RHP MSE A 208 MET SELENOMETHIONINE MODRES 4RHP MSE A 223 MET SELENOMETHIONINE MODRES 4RHP MSE A 227 MET SELENOMETHIONINE MODRES 4RHP MSE A 246 MET SELENOMETHIONINE MODRES 4RHP MSE A 258 MET SELENOMETHIONINE MODRES 4RHP MSE A 259 MET SELENOMETHIONINE MODRES 4RHP MSE A 281 MET SELENOMETHIONINE MODRES 4RHP MSE A 283 MET SELENOMETHIONINE MODRES 4RHP MSE B 137 MET SELENOMETHIONINE MODRES 4RHP MSE B 192 MET SELENOMETHIONINE MODRES 4RHP MSE B 208 MET SELENOMETHIONINE MODRES 4RHP MSE B 223 MET SELENOMETHIONINE MODRES 4RHP MSE B 227 MET SELENOMETHIONINE MODRES 4RHP MSE B 246 MET SELENOMETHIONINE MODRES 4RHP MSE B 258 MET SELENOMETHIONINE MODRES 4RHP MSE B 259 MET SELENOMETHIONINE MODRES 4RHP MSE B 281 MET SELENOMETHIONINE MODRES 4RHP MSE B 283 MET SELENOMETHIONINE MODRES 4RHP MSE B 302 MET SELENOMETHIONINE HET MSE A 137 8 HET MSE A 192 8 HET MSE A 208 8 HET MSE A 223 8 HET MSE A 227 8 HET MSE A 246 8 HET MSE A 258 8 HET MSE A 259 8 HET MSE A 281 8 HET MSE A 283 8 HET MSE B 137 8 HET MSE B 192 8 HET MSE B 208 8 HET MSE B 223 8 HET MSE B 227 8 HET MSE B 246 8 HET MSE B 258 8 HET MSE B 259 8 HET MSE B 281 8 HET MSE B 283 8 HET MSE B 302 8 HET PEF A 401 32 HETNAM MSE SELENOMETHIONINE HETNAM PEF DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE HETSYN PEF 3-[AMINOETHYLPHOSPHORYL]-[1,2-DI-PALMITOYL]-SN-GLYCEROL FORMUL 1 MSE 21(C5 H11 N O2 SE) FORMUL 3 PEF C37 H74 N O8 P FORMUL 4 HOH *90(H2 O) HELIX 1 1 SER A 95 GLU A 109 1 15 HELIX 2 2 PHE A 110 GLY A 115 1 6 HELIX 3 3 THR A 117 LEU A 128 1 12 HELIX 4 4 SER A 131 PHE A 138 5 8 HELIX 5 5 GLY A 142 LEU A 170 1 29 HELIX 6 6 LYS A 177 MSE A 192 1 16 HELIX 7 7 LEU A 193 GLU A 198 5 6 HELIX 8 8 HIS A 199 MSE A 208 1 10 HELIX 9 9 ASN A 212 GLY A 232 1 21 HELIX 10 10 ASN A 239 MSE A 259 1 21 HELIX 11 11 SER A 263 ASP A 265 5 3 HELIX 12 12 PHE A 266 MSE A 283 1 18 HELIX 13 13 SER B 95 LEU B 108 1 14 HELIX 14 14 PHE B 110 GLY B 115 1 6 HELIX 15 15 THR B 117 LEU B 128 1 12 HELIX 16 16 GLY B 142 LEU B 170 1 29 HELIX 17 17 LYS B 177 ARG B 191 1 15 HELIX 18 18 MSE B 192 ILE B 197 5 6 HELIX 19 19 HIS B 199 MSE B 208 1 10 HELIX 20 20 ASN B 212 GLY B 232 1 21 HELIX 21 21 ASN B 239 MSE B 259 1 21 HELIX 22 22 SER B 263 ASP B 265 5 3 HELIX 23 23 PHE B 266 MSE B 283 1 18 HELIX 24 24 GLY B 294 ASN B 310 1 17 LINK C SER A 136 N MSE A 137 1555 1555 1.33 LINK C MSE A 137 N PHE A 138 1555 1555 1.33 LINK C ARG A 191 N MSE A 192 1555 1555 1.32 LINK C MSE A 192 N LEU A 193 1555 1555 1.33 LINK C LEU A 207 N MSE A 208 1555 1555 1.33 LINK C MSE A 208 N LEU A 209 1555 1555 1.33 LINK C SER A 222 N MSE A 223 1555 1555 1.33 LINK C MSE A 223 N VAL A 224 1555 1555 1.32 LINK C ASP A 226 N MSE A 227 1555 1555 1.32 LINK C MSE A 227 N TRP A 228 1555 1555 1.33 LINK C ALA A 245 N MSE A 246 1555 1555 1.33 LINK C MSE A 246 N LEU A 247 1555 1555 1.33 LINK C VAL A 257 N MSE A 258 1555 1555 1.33 LINK C MSE A 258 N MSE A 259 1555 1555 1.33 LINK C MSE A 259 N GLN A 260 1555 1555 1.33 LINK C ALA A 280 N MSE A 281 1555 1555 1.32 LINK C MSE A 281 N ASN A 282 1555 1555 1.33 LINK C ASN A 282 N MSE A 283 1555 1555 1.33 LINK C SER B 136 N MSE B 137 1555 1555 1.33 LINK C MSE B 137 N PHE B 138 1555 1555 1.33 LINK C ARG B 191 N MSE B 192 1555 1555 1.33 LINK C MSE B 192 N LEU B 193 1555 1555 1.33 LINK C LEU B 207 N MSE B 208 1555 1555 1.33 LINK C MSE B 208 N LEU B 209 1555 1555 1.33 LINK C SER B 222 N MSE B 223 1555 1555 1.32 LINK C MSE B 223 N VAL B 224 1555 1555 1.34 LINK C ASP B 226 N MSE B 227 1555 1555 1.32 LINK C MSE B 227 N TRP B 228 1555 1555 1.34 LINK C ALA B 245 N MSE B 246 1555 1555 1.33 LINK C MSE B 246 N LEU B 247 1555 1555 1.33 LINK C VAL B 257 N MSE B 258 1555 1555 1.33 LINK C MSE B 258 N MSE B 259 1555 1555 1.33 LINK C MSE B 259 N GLN B 260 1555 1555 1.33 LINK C ALA B 280 N MSE B 281 1555 1555 1.33 LINK C MSE B 281 N ASN B 282 1555 1555 1.33 LINK C ASN B 282 N MSE B 283 1555 1555 1.33 LINK C MSE B 283 N GLY B 284 1555 1555 1.33 LINK C LEU B 301 N MSE B 302 1555 1555 1.33 LINK C MSE B 302 N GLY B 303 1555 1555 1.33 SITE 1 AC1 11 TRP A 240 TYR A 241 ARG A 244 ALA A 249 SITE 2 AC1 11 ASN A 252 SER A 262 HOH A 518 LEU B 217 SITE 3 AC1 11 TYR B 241 ARG B 244 ASN B 252 CRYST1 38.340 97.628 64.109 90.00 95.77 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026082 0.000000 0.002634 0.00000 SCALE2 0.000000 0.010243 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015678 0.00000